Home » Healthcare » Pharmaceuticals » Subcutaneous Immunoglobulin (SCIg) Market

Subcutaneous Immunoglobulin (SCIg) Market by Application (Primary Immunodeficiency Diseases, Secondary Immunodeficiency Diseases, Neurological Disorders, Bleeding Disorders, Others) By End-user (Hospital, Homecare, Clinics) – Growth, Future Prospects & Competitive Analysis, 2015-2027

Price: $4999

Published: | Report ID: 9932 | Report Format : PDF

Market Insights

The Subcutaneous Immunoglobulin (SCIg) market is expected to cross-market at USD 8,435.62 million in 2027 from USD 2,136.71 million in 2020. It is expected to grow at a CAGR of over 20.73% during the forecast period.

The plasma collected from numerous donors and processed to remove contamination is called immune globulin. Immune globulin is free from contamination to maintain the safety and integrity of the products. Immune globulin can be delivered in multiple ways. Immune globulin administered subcutaneously is called Subcutaneous Immunoglobulin (SCIg). It contains antibodies that can fight against many bacteria and viruses.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Key Market Drivers and Restraints

The global Subcutaneous Immunoglobulin (SCIg) market report delivers a depth analysis of this industry with a detailed analysis of significant factors hindering the growth, mobilizing the demand and future growth prospects of the global Subcutaneous Immunoglobulin (SCIg) industry.

Impact of COVID 19

COVID-19 outbreak in early 2020 has resulted in severe supply chain disruption, resulting in a significant decline in demand and supply of Subcutaneous Immunoglobulin (SCIg) worldwide. However, the economies started taking pace in the later half of 2020, restoring the demand and supply. However, as the world enters the second quarter of 2021, the second and third wave of COVID-19 in most parts of Europe, India, Brazil, and the U.S. is likely to affect the demand and supply of Subcutaneous Immunoglobulin (SCIg). This, in turn, is expected to affect the growth rate of Subcutaneous Immunoglobulin (SCIg).

U.S. to Dominate the global Subcutaneous Immunoglobulin (SCIg) market

Key geographies analyzed in the global Subcutaneous Immunoglobulin (SCIg) market include Europe, North America, Asia Pacific, Latin America (LATAM), the Middle East, and Africa. The global Subcutaneous Immunoglobulin (SCIg) market is dominated by the U.S., with over 35% share in 2020. Strong demand from North America will likely drive the Subcutaneous Immunoglobulin (SCIg) market.

Global Subcutaneous Immunoglobulin (SCIg) Market is Led by Strong Demand from Primary Immunodeficiency Diseases

Global Subcutaneous Immunoglobulin (SCIg) market is categorized into Neurological Disorders, Secondary Immunodeficiency Diseases, Primary Immunodeficiency Diseases, Bleeding Disorders, etc. Primary Immunodeficiency Diseases accounted for over 60% of the total revenue generated by the global Subcutaneous Immunoglobulin (SCIg) industry in 2020. The primary Immunodeficiency Diseases application segment is also expected to exhibit the fastest CAGR among all applications of Subcutaneous Immunoglobulin (SCIg) during the forecast period.

The homecare segment will rule the global Subcutaneous Immunoglobulin (SCIg)industry over the forecast period.

Hospitals, Homecare, and Clinics are major end-user segments of the global Subcutaneous Immunoglobulin (SCIg) market. The homecare segment is poised to dominate the global Subcutaneous Immunoglobulin (SCIg) demand over the forecast period. It accounted for over 60% of the Subcutaneous Immunoglobulin (SCIg) market by end-users. The homecare segment is growing in popularity because of its convenience, cost-effectiveness, and the most sought-after way to administer Subcutaneous Immunoglobulin (SCIg).

Overview:

Subcutaneous immunoglobulin is the biological molecules injected subcutaneously to cure certain diseases/disorders such as infectious diseases, immune deficiencies, and bleeding disorders, among others. Due to patient compliance, the preference for subcutaneous immunoglobulin is rising over the intravenous route of administration. The global subcutaneous immunoglobulin market is expected to witness lucrative growth during the forecast period owing to the growing burden of primary immunodeficiency diseases, the rising geriatric population, and opportunities for immunoglobulins for secondary immunodeficiency disease treatment.

The global subcutaneous immunoglobulin market is segmented based on the application, end-users, and geography. Based on the application, the global subcutaneous immunoglobulin market is segmented into secondary immunodeficiency diseases, primary immunodeficiency diseases, and other diseases. Other segments include neurological disorders, infectious diseases, bleeding disorders, etc. In 2017, the primary immunodeficiency diseases segment dominated the global market owing to the growing prevalence of such conditions and surging research and developments. Furthermore, the global market is segmented into home care, hospitals, and clinics based on the end-users. In 2017, the hospital segment led the market, and the homecare segment is the fastest-growing segment. The patient’s preference and ease of use for the subcutaneous immunoglobulin administration accounted for the rapid growth of the homecare segments.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

In 2017, North America accounted for a significant share of the global subcutaneous immunoglobulin market owing to the rise in the geriatric population, technological advancements, and the initial launch of products. According to the U.S. Census Bureau, the population equal to and above 60 years of age in the United States will rise to 12.67% in 2026 from 10.90%, which indicates the high demand for subcutaneous immunoglobulin during the forecast period. In addition, according to the Immune Deficiency Foundation, in 2015, approximately 55,000 patients in the United States were treated with primary immunodeficiency diseases, and the cases are expected to grow during the forecast period.

The manufacturers compete heavily in the market based on the pricing and the approaches to effectively deliver the immunoglobulin to the patient’s body. For instance, Shire Plc has developed a product, Hyquia, which consists of a dual vial unit, one for immunoglobulin infusion of 10% and another for recombinant human hyaluronidase. The simultaneous subcutaneous administration of both the formulations enhances the bioavailability of the immunoglobulin and allows the infusion of large volumes.

This report offers:

  • The prominent end-users for subcutaneous immunoglobulin (SCIg) across geographies.
  • The regional market comparison for subcutaneous immunoglobulin and the most attractive region for expanding geographical outreach or product launch.
  • The current trends in the subcutaneous immunoglobulin market at the granular level
  • Market sizing of the global subcutaneous immunoglobulin market for ten years from 2016 to 2026 and quantifies the market’s growth during the forecast period.
  • Mapping of the players based on the product offering, business strengths, strategic initiatives, product launches, geographical expansion, and profiling of major players.

Table of Content

Chapter 1 Preface 36

1.1 Report Description 36

1.1.1 Purpose of the Report 36

1.1.2 Target Audience 36

1.1.3 USP and Key Offerings 36

1.2 Research Scope 37

1.3 Research Methodology 38

1.3.1 Phase I – Secondary Research 38

1.3.2 Phase II – Primary Research 39

1.3.3 Phase III – Expert Panel Review 39

1.3.4 Assumptions 40

1.3.5 Approach Adopted 40

Chapter 2 Executive Summary 41

2.1 Market Snapshot: Global Subcutaneous Immunoglobulin (SCIg) Market 41

Chapter 3 Market Dynamics 42

3.1 Introduction 42

3.2 Market Dynamics 42

3.3 Key Growth Trends 43

3.3.1 Growing demand for Polyvalent IG across the world 43

3.3.2 Rising prevalence of Primary Immunodeficiencies 44

3.3.3 Increase in Plasma Collection 44

3.3.4 Growing Use of Immunoglobulins in Various Therapeutic Areas 44

3.4 Major Industry Challenges 46

3.4.1 Risks associated with SCIg 46

3.4.2 High Cost of Raw Materials 47

3.5 Key Growth Pockets 48

3.5.1 Cost benefits of SCIG as against IVIG 48

3.5.2 Technical Advancement and in the Field of Subcutaneous Immunoglobulin 48

3.5.3 Rising Geriatric Population Across the Globe 49

3.6 Attractive Investment Proposition, 2020 50

3.7 Application 50

3.8 End-user 51

3.9 Geography 52

3.10 Value Chain Analysis 53

Chapter 4 Market Positioning of Key Players, 2020 54

4.1 Company market share of key players, 2018 to 2020 54

4.2 Global Subcutaneous Immunoglobulin (SCIg) Revenue and Market Share by Manufacturer (2018-2020) 54

4.3 Global Subcutaneous Immunoglobulin (SCIg) Revenue and Market Share by Company (2018-2020) 55

4.4 Top 3 Players 56

Chapter 5 COVID 19 Impact on Subcutaneous Immunoglobulin (SCIg) Market 57

5.1 COVID 19 Outlook 57

5.1.1 Impact on Supply Chain and Production in Healthcare Industry 58

5.1.2 Impact on Import and Export 58

5.2 Pre and Post COVID 19 market 59

5.2.1 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, Pre and Post COVID 19 59

5.3 Macro-Economic Factors 60

5.4 Outlook for trade in 2020 and 2021 60

Chapter 6 Global Subcutaneous Immunoglobulin (SCIg) Market, By Application 61

6.1 Global Subcutaneous Immunoglobulin (SCIg) Market Share by Application, 2015 and 2027 61

6.1.1 Global Subcutaneous Immunoglobulin (SCIg) Market Share by Application, 2020 61

6.2 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Primary Immunodeficiency Diseases, 2015 – 2027 62

6.3 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Secondary Immunodeficiency Diseases, 2015 – 2027 62

6.4 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Neurological Disorders, 2015 – 2027 63

6.5 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Bleeding Disorders, 2015 – 2027 64

6.6 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Other Applications, 2015 – 2027 65

Chapter 7 Global Subcutaneous Immunoglobulin (SCIg) Market, By End-user 67

7.1 Global Subcutaneous Immunoglobulin (SCIg) Market Share by End-user, 2015 and 2027 67

7.1.1 Global Subcutaneous Immunoglobulin (SCIg) Market Share by End-user, 2020 67

7.2 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Hospital, 2015 – 2027 68

7.3 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Homecare, 2015 – 2027 69

7.4 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Clinics, 2015 – 2027 70

Chapter 8 North America Subcutaneous Immunoglobulin (SCIg) Market 71

8.1 North America Subcutaneous Immunoglobulin (SCIg) Market Share, By Country, 2020 71

8.2 North America by Country 72

8.2.1 North America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 72

8.2.2 North America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 72

8.3 North America by Application 73

8.3.1 North America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 73

8.3.2 North America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 73

8.4 North America by End-user 74

8.4.1 North America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 74

8.4.2 North America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 74

8.5 U.S. by Application 75

8.5.1 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 75

8.5.2 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 75

8.6 U.S. by End-user 76

8.6.1 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 76

8.6.2 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 76

8.7 Canada by Application 77

8.7.1 Canada Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 77

8.7.2 Canada Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 77

8.8 Canada by End-user 78

8.8.1 Canada Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 78

8.8.2 Canada Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 78

8.9 Mexico by Application 79

8.9.1 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 79

8.9.2 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 79

8.10 Mexico by End-user 80

8.10.1 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 80

8.10.2 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 80

Chapter 9 Europe Subcutaneous Immunoglobulin (SCIg) Market 81

9.1 Europe Subcutaneous Immunoglobulin (SCIg) Market Share, By Country, 2020 81

9.2 Europe by Country 82

9.2.1 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 82

9.2.2 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 83

9.3 Europe by Application 84

9.3.1 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 84

9.3.2 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 84

9.4 Europe by End-user 85

9.4.1 Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 85

9.4.2 Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 85

9.5 UK by Application 86

9.5.1 UK Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 86

9.5.2 UK Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 86

9.6 UK by End-user 87

9.6.1 UK Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 87

9.6.2 UK Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 87

9.7 France by Application 88

9.7.1 France Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 88

9.7.2 France Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 88

9.8 France by End-user 89

9.8.1 France Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 89

9.8.2 France Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 89

9.9 Germany by Application 90

9.9.1 Germany Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 90

9.9.2 Germany Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 90

9.10 Germany by End-user 91

9.10.1 Germany Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 91

9.10.2 Germany Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 91

9.11 Italy by Application 92

9.11.1 Italy Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 92

9.11.2 Italy Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 92

9.12 Italy by End-user 93

9.12.1 Italy Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 93

9.12.2 Italy Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 93

9.13 Spain by Application 94

9.13.1 Spain Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 94

9.13.2 Spain Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 94

9.14 Spain by End-user 95

9.14.1 Spain Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 95

9.14.2 Spain Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 95

9.15 Russia by Application 96

9.15.1 Russia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 96

9.15.2 Russia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 96

9.16 Russia by End-user 97

9.16.1 Russia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 97

9.16.2 Russia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 97

9.17 Belgium by Application 98

9.17.1 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 98

9.17.2 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 98

9.18 Belgium by End-user 99

9.18.1 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 99

9.18.2 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 99

9.19 Netherland by Application 100

9.19.1 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 100

9.19.2 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 100

9.20 Netherland by End-user 101

9.20.1 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 101

9.20.2 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 101

9.21 Austria by Application 102

9.21.1 Austria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 102

9.21.2 Austria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 102

9.22 Austria by End-user 103

9.22.1 Austria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 103

9.22.2 Austria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 103

9.23 Sweden by Application 104

9.23.1 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 104

9.23.2 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 104

9.24 Sweden by End-user 105

9.24.1 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 105

9.24.2 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 105

9.25 Poland by Application 106

9.25.1 Poland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 106

9.25.2 Poland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 106

9.26 Poland by End-user 107

9.26.1 Poland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 107

9.26.2 Poland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 107

9.27 Denmark by Application 108

9.27.1 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 108

9.27.2 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 108

9.28 Denmark by End-user 109

9.28.1 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 109

9.28.2 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 109

9.29 Switzerland by Application 110

9.29.1 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 110

9.29.2 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 110

9.30 Switzerland by End-user 111

9.30.1 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 111

9.30.2 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 111

9.31 Rest of Europe by Application 112

9.31.1 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 112

9.31.2 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 112

9.32 Rest of Europe by End-user 113

9.32.1 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 113

9.32.2 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 113

Chapter 10 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market 114

10.1 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market Share, By Country, 2020 114

10.2 Asia Pacific by Country 115

10.2.1 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 115

10.2.2 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 116

10.3 Asia Pacific by Application 117

10.3.1 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 117

10.3.2 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 117

10.4 Asia Pacific by End-user 118

10.4.1 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 118

10.4.2 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 118

10.5 China by Application 119

10.5.1 China Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 119

10.5.2 China Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 119

10.6 China by End-user 120

10.6.1 China Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 120

10.6.2 China Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 120

10.7 Japan by Application 121

10.7.1 Japan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 121

10.7.2 Japan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 121

10.8 Japan by End-user 122

10.8.1 Japan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 122

10.8.2 Japan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 122

10.9 South Korea by Application 123

10.9.1 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 123

10.9.2 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 123

10.10 South Korea by End-user 124

10.10.1 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 124

10.10.2 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 124

10.11 India by Application 125

10.11.1 India Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 125

10.11.2 India Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 125

10.12 India by End-user 126

10.12.1 India Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 126

10.12.2 India Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 126

10.13 Australia by Application 127

10.13.1 Australia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 127

10.13.2 Australia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 127

10.14 Australia by End-user 128

10.14.1 Australia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 128

10.14.2 Australia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 128

10.15 New Zealand by Application 129

10.15.1 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 129

10.15.2 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 129

10.16 New Zealand by End-user 130

10.16.1 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 130

10.16.2 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 130

10.17 Taiwan by Application 131

10.17.1 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 131

10.17.2 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 131

10.18 Taiwan by End-user 132

10.18.1 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 132

10.18.2 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 132

10.19 Southeast Asia by Application 133

10.19.1 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 133

10.19.2 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 133

10.20 Southeast Asia by End-user 134

10.20.1 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 134

10.20.2 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 134

10.21 Central Asia by Application 135

10.21.1 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 135

10.21.2 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 135

10.22 Central Asia by End-user 136

10.22.1 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 136

10.22.2 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 136

10.23 Rest of Asia Pacific by Application 137

10.23.1 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 137

10.23.2 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 137

10.24 Rest of Asia Pacific by End-user 138

10.24.1 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 138

10.24.2 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 138

Chapter 11 Latin America Subcutaneous Immunoglobulin (SCIg) Market 139

11.1 Latin America Subcutaneous Immunoglobulin (SCIg) Market Share, By Country, 2020 139

11.2 Latin America by Country 140

11.2.1 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 140

11.2.2 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 140

11.3 Latin America by Application 141

11.3.1 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 141

11.3.2 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 141

11.4 Latin America by End-user 142

11.4.1 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 142

11.4.2 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 142

11.5 Brazil by Application 143

11.5.1 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 143

11.5.2 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 143

11.6 Brazil by End-user 144

11.6.1 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 144

11.6.2 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 144

11.7 Argentina by Application 145

11.7.1 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 145

11.7.2 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 145

11.8 Argentina by End-user 146

11.8.1 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 146

11.8.2 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 146

11.9 Peru by Application 147

11.9.1 Peru Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 147

11.9.2 Peru Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 147

11.10 Peru by End-user 148

11.10.1 Peru Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 148

11.10.2 Peru Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 148

11.11 Chile by Application 149

11.11.1 Chile Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 149

11.11.2 Chile Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 149

11.12 Chile by End-user 150

11.12.1 Chile Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 150

11.12.2 Chile Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 150

11.13 Colombia by Application 151

11.13.1 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 151

11.13.2 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 151

11.14 Colombia by End-user 152

11.14.1 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 152

11.14.2 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 152

11.15 Rest of Latin America by Application 153

11.15.1 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 153

11.15.2 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 153

11.16 Rest of Latin America by End-user 154

11.16.1 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 154

11.16.2 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 154

Chapter 12 Middle East Subcutaneous Immunoglobulin (SCIg) Market 155

12.1 Middle East Subcutaneous Immunoglobulin (SCIg) Market Share, By Country, 2020 155

12.2 Middle East by Country 156

12.2.1 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 156

12.2.2 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 156

12.3 Middle East by Application 157

12.3.1 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 157

12.3.2 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 157

12.4 Middle East by End-user 158

12.4.1 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 158

12.4.2 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 158

12.5 UAE by Application 159

12.5.1 UAE Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 159

12.5.2 UAE Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 159

12.6 UAE by End-user 160

12.6.1 UAE Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 160

12.6.2 UAE Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 160

12.7 KSA by Application 161

12.7.1 KSA Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 161

12.7.2 KSA Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 161

12.8 KSA by End-user 162

12.8.1 KSA Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 162

12.8.2 KSA Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 162

12.9 Israel by Application 163

12.9.1 Israel Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 163

12.9.2 Israel Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 163

12.10 Israel by End-user 164

12.10.1 Israel Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 164

12.10.2 Israel Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 164

12.11 Turkey by Application 165

12.11.1 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 165

12.11.2 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 165

12.12 Turkey by End-user 166

12.12.1 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 166

12.12.2 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 166

12.13 Iran by Application 167

12.13.1 Iran Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 167

12.13.2 Iran Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 167

12.14 Iran by End-user 168

12.14.1 Iran Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 168

12.14.2 Iran Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 168

12.15 Rest of Middle East by Application 169

12.15.1 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 169

12.15.2 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 169

12.16 Rest of Middle East by End-user 170

12.16.1 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 170

12.16.2 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 170

Chapter 13 Africa Subcutaneous Immunoglobulin (SCIg) Market 171

13.1 Africa Subcutaneous Immunoglobulin (SCIg) Market Share, By Country, 2020 171

13.2 Africa by Country 172

13.2.1 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 172

13.2.2 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 172

13.3 Africa by Application 173

13.3.1 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 173

13.3.2 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 173

13.4 Africa by End-user 174

13.4.1 Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 174

13.4.2 Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 174

13.5 South Africa by Application 175

13.5.1 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 175

13.5.2 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 175

13.6 South Africa by End-user 176

13.6.1 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 176

13.6.2 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 176

13.7 Egypt by Application 177

13.7.1 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 177

13.7.2 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 177

13.8 Egypt by End-user 178

13.8.1 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 178

13.8.2 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 178

13.9 Nigeria by Application 179

13.9.1 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 179

13.9.2 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 179

13.10 Nigeria by End-user 180

13.10.1 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 180

13.10.2 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 180

13.11 The East African Community (EAC) by Application 181

13.11.1 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 181

13.11.2 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 181

13.12 The East African Community (EAC) by End-user 182

13.12.1 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 182

13.12.2 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 182

13.13 Rest of Africa by Application 183

13.13.1 Rest of Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 183

13.13.2 Rest of Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 183

13.14 Rest of Africa by End-user 184

13.14.1 Rest of Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 184

13.14.2 Rest of Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 184

Chapter 14 Company Profile 185

14.1 Biotest AG 185

14.1.1 Business Overview 185

14.1.2 Biotest AG Subcutaneous Immunoglobulin (SCIg) Application and End-users 186

14.1.3 Biotest AG Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 187

14.2 CSL Limited 188

14.2.1 Business Overview 188

14.2.2 CSL Limited Subcutaneous Immunoglobulin (SCIg) Application and End-users 189

14.2.3 CSL Limited Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 190

14.3 Grifols SA 191

14.3.1 Business Overview 191

14.3.2 Grifols SA Subcutaneous Immunoglobulin (SCIg) Application and End-users 192

14.3.3 Grifols SA Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 192

14.4 Kedrion S.p.A 193

14.4.1 Business Overview 193

14.4.2 Kedrion S.p.A Subcutaneous Immunoglobulin (SCIg) Application and End-users 194

14.4.3 Kedrion S.p.A Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 194

14.5 Octapharma AG 195

14.5.1 Business Overview 195

14.5.2 Octapharma AG Subcutaneous Immunoglobulin (SCIg) Application and End-users 196

14.5.3 Octapharma AG Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 197

14.6 Takeda Pharmaceutical Company Limited (Shire) 198

14.6.1 Business Overview 198

14.6.2 Takeda Pharmaceutical Company Limited (Shire) Subcutaneous Immunoglobulin (SCIg) Application and End-users 199

14.6.3 Takeda Pharmaceutical Company Limited (Shire) Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 200

14.7 Bio Products Laboratory Ltd. 201

14.7.1 Business Overview 201

14.7.2 Bio Products Laboratory Ltd. Subcutaneous Immunoglobulin (SCIg) Application and End-users 202

14.7.3 Bio Products Laboratory Ltd. Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 202

14.8 LFB S.A. 203

14.8.1 Business Overview 203

14.8.2 LFB S.A. Subcutaneous Immunoglobulin (SCIg) Application and End-users 204

14.8.3 LFB S.A. Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 204

Chapter 15 Subcutaneous Immunoglobulin (SCIg) Manufacturing Cost Analysis 205

15.1 Manufacturing cost structure of plasma industry Vs pharmaceutical industry 205

15.1.1 Raw Material Cost Analysis 207

15.1.2 Labor Cost Analysis 207

Chapter 16 Marketing Strategy Analysis 208

16.1 Marketing Channels Status of Collagen 208

16.1.1 Direct Marketing 208

16.1.2 Indirect Marketing 208

16.1.3 Marketing Channel Development Trend 208

16.2 Market Positioning 209

16.2.1 Pricing Strategy 209

16.2.2 Brand Strategy 209

List of Figures

FIG. 1 Global Subcutaneous Immunoglobulin (SCIg) Market: Research Methodology 39

FIG. 2 Top-Down and Bottom Up Approach 41

FIG. 3 The Global Polyvalent IG Market (IVIG and SCIG) from 1986 to 2016, with Projected Global Demand Through 2024 44

FIG. 4 Market Attractiveness Analysis, by Application 51

FIG. 5 Market Attractiveness Analysis, by End-user 52

FIG. 6 Market Attractiveness Analysis, by Geography 53

FIG. 7 Value Chain Analysis 54

FIG. 8 Top 3 Company Share Analysis, 2020 57

FIG. 9 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, Pre and Post COVID 19 60

FIG. 10 Global Subcutaneous Immunoglobulin (SCIg) Market Share by Application, 2020 62

FIG. 11 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Primary Immunodeficiency Diseases, 2015 – 2027 63

FIG. 12 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Secondary Immunodeficiency Diseases, 2015 – 2027 63

FIG. 13 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Neurological Disorders, 2015 – 2027 64

FIG. 14 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Bleeding Disorders, 2015 – 2027 65

FIG. 15 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Application 6, 2015 – 2027 66

FIG. 16 Global Subcutaneous Immunoglobulin (SCIg) Market Share by End-user, 2020 68

FIG. 17 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Hospital, 2015 – 2027 69

FIG. 18 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Homecare, 2015 – 2027 70

FIG. 19 Global Subcutaneous Immunoglobulin (SCIg) Market Revenue, By Clinics, 2015 – 2027 71

FIG. 20 North America Subcutaneous Immunoglobulin (SCIg) Market Share by Country, 2020 72

FIG. 21 Europe Subcutaneous Immunoglobulin (SCIg) Market Share by Country, 2020 82

FIG. 22 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market Share by Country, 2020 115

FIG. 23 Latin America Subcutaneous Immunoglobulin (SCIg) Market Share by Country, 2020 140

FIG. 24 Middle East Subcutaneous Immunoglobulin (SCIg) Market Share by Country, 2020 156

FIG. 25 Africa Subcutaneous Immunoglobulin (SCIg) Market Share by Country, 2020 172

FIG. 26 Manufacturing Cost Structure of Subcutaneous Immunoglobulin (SCIg) Vs Pharmaceutical Industry 206

FIG. 27 Manufacturing Cost Structure of Subcutaneous Immunoglobulin (SCIg) 207

List of Tables

TABLE 1 Market Snapshot: Global Subcutaneous Immunoglobulin (SCIg) Market 41

TABLE 2 Drivers Of The Global Subcutaneous Immunoglobulin (SCIg) Market: Impact Analysis 42

TABLE 3 Restraints Of The Global Subcutaneous Immunoglobulin (SCIg) Market: Impact Analysis 46

TABLE 4 Global Subcutaneous Immunoglobulin (SCIg) Revenue by Manufacturer (2018-2020) (USD Million) 54

TABLE 5 Global Subcutaneous Immunoglobulin (SCIg) Revenue by Company (2018-2020) (%) 55

TABLE 6 COVID-19 Impact Analysis by Production, Import, Export and Demand 58

TABLE 7 Estimated Impact of The Coronavirus (Covid-19) Epidemic on The Subcutaneous Immunoglobulin (SCIg) Market Size In 2020, By Scenario 59

TABLE 8 North America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 72

TABLE 9 North America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 72

TABLE 10 North America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 73

TABLE 11 North America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 73

TABLE 12 North America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 74

TABLE 13 North America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 74

TABLE 14 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 75

TABLE 15 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 75

TABLE 16 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 76

TABLE 17 U.S. Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 76

TABLE 18 Canada Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 77

TABLE 19 Canada Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 77

TABLE 20 Canada Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 78

TABLE 21 Canada Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 78

TABLE 22 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 79

TABLE 23 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 79

TABLE 24 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 80

TABLE 25 Mexico Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 80

TABLE 26 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 82

TABLE 27 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 83

TABLE 28 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 84

TABLE 29 Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 84

TABLE 30 Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 85

TABLE 31 Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 85

TABLE 32 UK Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 86

TABLE 33 UK Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 86

TABLE 34 UK Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 87

TABLE 35 UK Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 87

TABLE 36 France Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 88

TABLE 37 France Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 88

TABLE 38 France Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 89

TABLE 39 France Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 89

TABLE 40 Germany Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 90

TABLE 41 Germany Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 90

TABLE 42 Germany Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 91

TABLE 43 Germany Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 91

TABLE 44 Italy Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 92

TABLE 45 Italy Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 92

TABLE 46 Italy Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 93

TABLE 47 Italy Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 93

TABLE 48 Spain Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 94

TABLE 49 Spain Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 94

TABLE 50 Spain Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 95

TABLE 51 Spain Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 95

TABLE 52 Russia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 96

TABLE 53 Russia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 96

TABLE 54 Russia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 97

TABLE 55 Russia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 97

TABLE 56 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 98

TABLE 57 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 98

TABLE 58 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 99

TABLE 59 Belgium Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 99

TABLE 60 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 100

TABLE 61 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 100

TABLE 62 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 101

TABLE 63 Netherland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 101

TABLE 64 Austria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 102

TABLE 65 Austria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 102

TABLE 66 Austria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 103

TABLE 67 Austria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 103

TABLE 68 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 104

TABLE 69 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 104

TABLE 70 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 105

TABLE 71 Sweden Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 105

TABLE 72 Poland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 106

TABLE 73 Poland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 106

TABLE 74 Poland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 107

TABLE 75 Poland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 107

TABLE 76 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 108

TABLE 77 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 108

TABLE 78 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 109

TABLE 79 Denmark Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 109

TABLE 80 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 110

TABLE 81 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 110

TABLE 82 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 111

TABLE 83 Switzerland Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 111

TABLE 84 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 112

TABLE 85 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 112

TABLE 86 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 113

TABLE 87 Rest of Europe Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 113

TABLE 88 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 115

TABLE 89 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 116

TABLE 90 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 117

TABLE 91 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 117

TABLE 92 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 118

TABLE 93 Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 118

TABLE 94 China Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 119

TABLE 95 China Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 119

TABLE 96 China Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 120

TABLE 97 China Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 120

TABLE 98 Japan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 121

TABLE 99 Japan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 121

TABLE 100 Japan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 122

TABLE 101 Japan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 122

TABLE 102 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 123

TABLE 103 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 123

TABLE 104 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 124

TABLE 105 South Korea Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 124

TABLE 106 India Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 125

TABLE 107 India Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 125

TABLE 108 India Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 126

TABLE 109 India Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 126

TABLE 110 Australia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 127

TABLE 111 Australia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 127

TABLE 112 Australia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 128

TABLE 113 Australia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 128

TABLE 114 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 129

TABLE 115 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 129

TABLE 116 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 130

TABLE 117 New Zealand Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 130

TABLE 118 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 131

TABLE 119 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 131

TABLE 120 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 132

TABLE 121 Taiwan Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 132

TABLE 122 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 133

TABLE 123 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 133

TABLE 124 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 134

TABLE 125 Southeast Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 134

TABLE 126 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 135

TABLE 127 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 135

TABLE 128 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 136

TABLE 129 Central Asia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 136

TABLE 130 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 137

TABLE 131 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 137

TABLE 132 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 138

TABLE 133 Rest of Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 138

TABLE 134 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 140

TABLE 135 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 140

TABLE 136 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 141

TABLE 137 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 141

TABLE 138 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 142

TABLE 139 Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 142

TABLE 140 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 143

TABLE 141 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 143

TABLE 142 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 144

TABLE 143 Brazil Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 144

TABLE 144 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 145

TABLE 145 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 145

TABLE 146 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 146

TABLE 147 Argentina Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 146

TABLE 148 Peru Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 147

TABLE 149 Peru Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 147

TABLE 150 Peru Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 148

TABLE 151 Peru Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 148

TABLE 152 Chile Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 149

TABLE 153 Chile Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 149

TABLE 154 Chile Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 150

TABLE 155 Chile Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 150

TABLE 156 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 151

TABLE 157 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 151

TABLE 158 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 152

TABLE 159 Colombia Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 152

TABLE 160 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 153

TABLE 161 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 153

TABLE 162 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 154

TABLE 163 Rest of Latin America Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 154

TABLE 164 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 156

TABLE 165 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 156

TABLE 166 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 157

TABLE 167 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 157

TABLE 168 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 158

TABLE 169 Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 158

TABLE 170 UAE Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 159

TABLE 171 UAE Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 159

TABLE 172 UAE Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 160

TABLE 173 UAE Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 160

TABLE 174 KSA Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 161

TABLE 175 KSA Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 161

TABLE 176 KSA Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 162

TABLE 177 KSA Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 162

TABLE 178 Israel Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 163

TABLE 179 Israel Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 163

TABLE 180 Israel Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 164

TABLE 181 Israel Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 164

TABLE 182 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 165

TABLE 183 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 165

TABLE 184 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 166

TABLE 185 Turkey Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 166

TABLE 186 Iran Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 167

TABLE 187 Iran Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 167

TABLE 188 Iran Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 168

TABLE 189 Iran Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 168

TABLE 190 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 169

TABLE 191 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 169

TABLE 192 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 170

TABLE 193 Rest of Middle East Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 170

TABLE 194 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2015 – 2020 (USD Million) 172

TABLE 195 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Country, 2021 – 2027 (USD Million) 172

TABLE 196 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 173

TABLE 197 Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 173

TABLE 198 Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 174

TABLE 199 Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 174

TABLE 200 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 175

TABLE 201 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 175

TABLE 202 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 176

TABLE 203 South Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 176

TABLE 204 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 177

TABLE 205 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 177

TABLE 206 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 178

TABLE 207 Egypt Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 178

TABLE 208 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 179

TABLE 209 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 179

TABLE 210 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 180

TABLE 211 Nigeria Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 180

TABLE 212 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 181

TABLE 213 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 181

TABLE 214 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 182

TABLE 215 The East African Community (EAC) Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 182

TABLE 216 Rest of Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2015 – 2020 (USD Million) 183

TABLE 217 Rest of Africa Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2021 – 2027 (USD Million) 183

TABLE 218 Rest of Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2015 – 2020 (USD Million) 184

TABLE 219 Africa Subcutaneous Immunoglobulin (SCIg) Market, By End-user, 2021 – 2027 (USD Million) 184

TABLE 220 Biotest AG Basic Information, Location and Competitors 185

TABLE 221 Biotest AG Subcutaneous Immunoglobulin (SCIg) Application and End-users 186

TABLE 222 Biotest AG Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 187

TABLE 223 CSL Limited Basic Information, Location and Competitors 188

TABLE 224 CSL Limited Subcutaneous Immunoglobulin (SCIg) Application and End-users 189

TABLE 225 CSL Limited Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 190

TABLE 226 Grifols SA Basic Information, Location and Competitors 191

TABLE 227 Grifols SA Subcutaneous Immunoglobulin (SCIg) Application and End-users 192

TABLE 228 Grifols SA Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 192

TABLE 229 Kedrion S.p.A Basic Information, Location and Competitors 193

TABLE 230 Kedrion S.p.A Subcutaneous Immunoglobulin (SCIg) Application and End-users 194

TABLE 231 Kedrion S.p.A Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 194

TABLE 232 Octapharma AG Basic Information, Location and Competitors 195

TABLE 233 Octapharma AG Subcutaneous Immunoglobulin (SCIg) Application and End-users 196

TABLE 234 Octapharma AG Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 197

TABLE 235 Takeda Pharmaceutical Company Limited (Shire) Basic Information, Location and Competitors 198

TABLE 236 Takeda Pharmaceutical Company Limited (Shire) Subcutaneous Immunoglobulin (SCIg) Application and End-users 199

TABLE 237 Takeda Pharmaceutical Company Limited (Shire) Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 200

TABLE 238 Bio Products Laboratory Ltd. Basic Information, Location and Competitors 201

TABLE 239 Bio Products Laboratory Ltd. Subcutaneous Immunoglobulin (SCIg) Application and End-users 202

TABLE 240 Bio Products Laboratory Ltd. Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 202

TABLE 241 LFB S.A. Basic Information, Location and Competitors 203

TABLE 242 LFB S.A. Subcutaneous Immunoglobulin (SCIg) Application and End-users 204

TABLE 243 LFB S.A. Subcutaneous Immunoglobulin (SCIg) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 204

Frequently Asked Questions

What are the consequences of COVID 19 on global Subcutaneous Immunoglobulin (SCIg) industry?

The market is impacted slightly from the COVID 19 pandemic and growth rate has been declined from over 18 to around 5%

Which are the key application segment expected to drive the demand Subcutaneous Immunoglobulin (SCIg)?

Strong demand from Primary Immunodeficiency Diseases segment is expected to drive the demand for Subcutaneous Immunoglobulin (SCIg)

Who are the key players in the global Subcutaneous Immunoglobulin (SCIg) industry?

Biotest AG, CSL Limited, Grifols SA, Kedrion S.p.A, Octapharma AG, Takeda Pharmaceutical Company Limited (Shire), Bio Products Laboratory Ltd. and LFB S.A. are the key players operating in this market

Which is the fastest growing end-user segment for global Subcutaneous Immunoglobulin (SCIg) industry?

Homecare segment is expected to exhibit fastest CAGR of over 20% during the forecast period

Which is the leading regional market for global Subcutaneous Immunoglobulin (SCIg) industry?

North America has the largest share owing to various developments happening in this space

Trigeminal Neuralgia Treatment Market

Published:
Report ID: 11788

Pompe Disease Therapeutics Market

Published:
Report ID: 5989

Pre-Menstrual Syndrome Treatment Market

Published:
Report ID: 11248

Vial Adaptors for Reconstitution Drug Market

Published:
Report ID: 15561

Psychedelic Medicine Market

Published:
Report ID: 41606

Hospital Infection Prevention And Control Market

Published:
Report ID: 7217

Nanoparticle Formulation Market

Published:
Report ID: 41106

Animal Drug Compounding Market

Published:
Report ID: 40870

Antibiotics Market

Published:
Report ID: 40728

Conjugation and Labeling Services Market

Published:
Report ID: 40756

Antiviral Drugs Market

Published:
Report ID: 40681

Intravitreal Injectable Market

Published:
Report ID: 7250

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN